Phase 2 Completed N=236 Randomized Treatment

Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder

HIV · Schizophrenia · schizoaffective disorder · Bipolar Disorder

Source: ClinicalTrials.gov NCT00316303 ↗

Enrolled (actual)

236

Serious AEs

0.0%

Results posted

May 2013

Primary outcomePrimary: Change in Immunization Status — 73; 4 participants — p=<0.001

Summary

This study will determine the effectiveness of the STIRR (Screen, Test, Immunize, Reduce risk, and Refer) intervention in increasing rates of testing, immunization, referral, and treatment for blood-borne diseases, such as hepatitis and HIV, in people with both a mental disorder and a substance abuse disorder.

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in Immunization Status	73; 4	<0.001 sig
PRIMARY Tested for Hepatitis C	70; 10	<0.001 sig
PRIMARY Tested for Hepatitis B	69; 14	<0.001 sig
PRIMARY Tested for HIV	18; 6	0.011 sig
PRIMARY Referral for Medical Care	17; 12	0.6

Eligibility Criteria

Inclusion Criteria

DSM-IV diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or major depression
Diagnosis of a substance use disorder
Enrolled in clinical care at Creative Alternatives or People Encouraging People for at least 3 months

Exclusion Criteria

Pregnant

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00316303). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.